Tonix Pharmaceuticals Holding Stock Analysis

Tonix Stock Analysis Notes

The company has price-to-book ratio of 0.48. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tonix Pharmaceuticals recorded a loss per share of 80.39. The entity last dividend was issued on the 1st of November 2019. The firm had 1:32 split on the 10th of June 2024. Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. The company was founded in 2007 and is headquartered in Chatham, New Jersey. Tonix Pharm operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 73 people. To find out more about Tonix Pharmaceuticals Holding contact the company at 862 799 8599 or learn more at https://www.tonixpharma.com.

Tonix Pharmaceuticals Investment Alerts

Tonix Pharmaceuticals Upcoming and Recent Events

Tonix Largest EPS Surprises

View All Earnings Estimates

Tonix Stock Institutional Investors

Note, although Tonix Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Tonix Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 35.51 M.

Tonix Profitablity

Management Efficiency

Tonix Pharmaceuticals has return on total asset (ROA) of (0.5172) % which means that it has lost $0.5172 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.6324) %, meaning that it created substantial loss on money invested by shareholders. Tonix Pharmaceuticals' management efficiency ratios could be used to measure how well Tonix Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/23/2024, Return On Tangible Assets is likely to drop to -0.85. In addition to that, Return On Capital Employed is likely to drop to -0.92. At this time, Tonix Pharmaceuticals' Total Current Liabilities is relatively stable compared to the past year. As of 11/23/2024, Liabilities And Stockholders Equity is likely to grow to about 162.2 M, while Non Current Liabilities Other is likely to drop slightly above 436 K.

Technical Drivers

As of the 23rd of November, Tonix Pharmaceuticals has the Coefficient Of Variation of (1,721), variance of 69.97, and Risk Adjusted Performance of (0.04). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tonix Pharmaceuticals, as well as the relationship between them.

Tonix Pharmaceuticals Price Movement Analysis

Tonix Pharmaceuticals Insider Trading Activities

Tonix Pharmaceuticals Outstanding Bonds

Tonix Pharmaceuticals Predictive Daily Indicators

Tonix Pharmaceuticals Forecast Models

Tonix Pharmaceuticals' time-series forecasting models are one of many Tonix Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tonix Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Tonix Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tonix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tonix Pharmaceuticals. By using and applying Tonix Stock analysis, traders can create a robust methodology for identifying Tonix entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Tonix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Tonix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Tonix Pharmaceuticals Holding stock analysis indicators help investors evaluate how Tonix Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Tonix Pharmaceuticals shares will generate the highest return on investment. By understating and applying Tonix Pharmaceuticals stock analysis, traders can identify Tonix Pharmaceuticals position entry and exit signals to maximize returns.

When running Tonix Pharmaceuticals' price analysis, check to measure Tonix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tonix Pharmaceuticals is operating at the current time. Most of Tonix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tonix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tonix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tonix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.